Oppenheimer Emerging Growth N
6803 South Tucson Way N/a Centennial CO 80112-3924
Map
Phone: 800-225-5677
| Category: | Mid-Cap Growth | | Fund Family: | OppenheimerFunds | | Net Assets: | 9.76M | | Year-to-Date Return: | 16.12% | | Yield: | 0.00% | | Morningstar Rating: |  | | Fund Inception Date: | 01-Mar-01 |
|
Ronald J. Zibelli, Jr.
Lead Manager since
30-Jun-07 | | | Zibelli is a vice president at Oppenheimer. Prior to joining the firm, he spent six years at Merrill Lynch, during which time he was a managing director and Small Cap Growth Team leader, responsible for managing 11 portfolios. Prior to joining Merrill Lynch, Zibelli spent 12 years with Chase Manhattan Bank, including two years as senior portfolio manager at Chase Asset Management. Zibelli holds the Chartered Financial Analyst designation. |
| Min Initial Investment: | $500,000 | | Min Initial Investment, IRA: | $500,000 | | Min Initial Investment, AIP: | NaN | | Min Subsequent Investment: | $0 | | Min Subsequent Investment, IRA: | $0 | | Min Subsequent Investment, AIP: | N/A |
|
| |
| The investment seeks capital appreciation. The fund invests mainly in common stocks of U.S. companies that have above-average growth rates. The Fund has no fixed ratio for small-cap and mid-cap stocks in its portfolio. It currently focuses on U.S. companies but may buy stocks of foreign companies as well. The Fund's foreign investments are primarily in developed market countries although emerging markets are not excluded from consideration. Foreign investing is not a principal strategy, however the Fund has no limits on its investments in foreign securities. |
| Last Dividend
| YFT_NOT_APPLICABLE_ABBREVIATION | | Last Cap Gain
(11-Dec-07):
| 1.64 | | Annual Holdings Turnover
| YFT_NOT_APPLICABLE_ABBREVIATION | | Average for Category:
| 125.67% |
|
| Expense | OEGNX | Category
Avg | | Total Expense Ratio: | 1.65%
| 1.45% | | Max 12b1 Fee: | 0.50%
| N/A | | Max Front End Sales Load: | %
| 5.39% | | Max Deferred Sales Load: | 1.00%
| 2.68% | | 3 Yr Expense Projection*: |
$ 596 | $714 | | 5 Yr Expense Projection*: |
$ 1,026 | $1,046 | | 10 Yr Expense Projection*: |
$ 2,221 | $2,067 |
|
|
1.79% Nasdaq 
Profile
